Evidence map›Paper›PMID 38940214›Full record

ArticleJournal of complementary & integrative medicine2024

Pharmacognostical characterization, GC-MS profiling, and elemental analysis of

Jyoti Rathi, Satyender Kumar, Rakesh K Sindhu, Anju Dhiman, Samriti Faujdar

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of complementary & integrative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jyoti RathiDepartment of Pharmacy, 29803 Banasthali Vidyapith , Jaipur, Rajasthan, India.
Satyender KumarSchool of Pharmacy, Sharda University, Greater Noida, Uttar Pradesh, India.ORCID https://orcid.org/0000-0001-6859-0850
Rakesh K SindhuSchool of Pharmacy, Sharda University, Greater Noida, Uttar Pradesh, India.
Anju DhimanDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India.
Samriti FaujdarDepartment of Pharmacy, 29803 Banasthali Vidyapith , Jaipur, Rajasthan, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe study provides a thorough examination of the rhizomes of

methodsThe study examines the pharmacognostical characteristics, GC-MS profiling, and elemental analysis of the substance to determine its potential for use in medicine. The presence of heavy metal contamination in herbal products is a significant issue, which necessitates the use of Atomic Absorption Spectrophotometry to quantitatively analyze eight elements.

resultsThe investigation validates the existence of crucial trace elements while guaranteeing that the levels of heavy metals are within the toxicity limits set by the World Health Organization. This indicates that the rhizome is safe for medicinal purposes. The selection of a solvent has a substantial impact on the efficiency of extraction. Acetone has the highest extraction yield, followed by ethanol and ethyl acetate. The GC-MS analysis uncovers a wide range of phytochemicals, such as alkaloids, flavonoids, phenols, tannins, steroids, and proteins. Additionally, particular solvents exclusively detect specific molecules. Epicurzerenone and zederone are chemicals that show promise for use in reducing inflammation and fighting cancer.

conclusionsOn the basis of results it can be concluded that rhizome's quality based on acceptable physicochemical characteristics and provides a strong basis for future pharmacological research. The research has potential for the development of novel organic drugs, utilizing the abundant phytochemical composition of

Indexed as

CurcumaPhytochemicalsPlant ExtractsRhizomeGas Chromatography-Mass SpectrometryHumansMetals, HeavyPublic HealthMetals, HeavyPhytochemicalsPlant ExtractsCurcuma caesia Roxb.dietary supplementelemental analysisGC-MS profilingpharmacognostical parameters

Identifiers

PMID38940214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.